ScreenerHero
ALGAEFERMENTALG
EPA · FR · Healthcare · Biotechnology · fermentalg.com
0.4690EUR-0.42%Mkt Cap: 60.29M $P/E: —

Fermentalg SA provides biosolutions based on aquatic micro-organisms in Europe, North America, Asia, and internationally. It offers DHA ORIGINS, a plant-based DHA oil; KALVEA PLUS, a nutritious algal protein concentrate …

Industry Peers

Biotechnology
Screen all
VX1
Vertex Pharmaceuticals Incorporated
$130.23BUSDP/E 32.1
VRTX
Vertex Pharmaceuticals Incorporated
$139.84BUSDP/E 32.2
REGN
Regeneron Pharmaceuticals, Inc.
$85.11BUSDP/E 20.4
MRNA
Moderna, Inc.
$69.62BUSD
ARGX
argenx SE
$61.34BUSDP/E 39.8
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$46.01BUSD
ONC
BeOne Medicines AG
$41.76BUSDP/E 66.2
RPRX
Royalty Pharma Plc Class A
$35.67BUSDP/E 33.2
ALNY
Alnylam Pharmaceuticals, Inc.
$32.46BUSDP/E 42.3
INSM
Insmed Incorporated
$28.53BUSD
22UA
BioNTech SE
$26.14BUSD
INCY
Incyte Corporation
$25.79BUSDP/E 16.2
GMAB
Genmab A/S
$20.83BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$17.03BUSDP/E 20.0
BBIO
BridgeBio Pharma, Inc.
$16.41BUSD
EXEL
Exelixis, Inc.
$13.48BUSDP/E 17.1
BMRN
BioMarin Pharmaceutical Inc.
$13.42BUSDP/E 187.4
CORT
Corcept Therapeutics Incorporated
$12.87BUSDP/E 264.5

Key Statistics

Company
Market Cap60.29M $
Enterprise Value46.75M $
Revenue (TTM)14.55M $
Gross Profit2.49M $
Net Income (TTM)-10.26M $
Revenue/Share0.1446 USD
Last Price0.4690 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees64
CountryFR
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-11.60
PEG—
EV/EBITDA-4.75
EV/Revenue3.21
P/S4.15
P/B1.77
EPS (TTM)-0.09
EPS (Forward)-0.04
52W Range
0.400029% of range0.6400
52W High0.6400 EUR
52W Low0.4000 EUR
Profitability
Gross Margin17.12%
Oper. Margin-100.16%
EBITDA Margin-67.66%
Profit Margin-70.51%
ROE-37.48%
ROA-25.88%
Growth
Revenue Growth11.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-7.16M $
CapEx (TTM)1.67M $
FCF Margin-42.74%
FCF Yield-10.31%
Net Debt-1.70M $
Net Debt/EBITDA0.17
Balance Sheet
Debt/Equity0.20
Current Ratio1.96
Quick Ratio1.82
Book Value/Sh0.2620 EUR
Cash/Share0.0690 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)0.6400 EUR
Upside (mean)+36.5%
Target Range0.6300 EUR – 0.6500 EUR
€0.6300+36.5% to mean€0.6500
# Analysts2
Ownership
Shares Out.119.79M
Float61.95M
Insiders15.63%
Institutions17.93%
Technical
SMA 500.4848 (-3.2%)
SMA 2000.4747 (-1.2%)
Beta1.04
S&P 52W Chg18.16%
Avg Vol (30d)78.75K
Avg Vol (10d)42.01K
Technical Indicators
RSI (14)46.0
MACD-0.0051
MACD Signal-0.0053
MACD Hist.+0.0002
BB Upper0.4871 EUR
BB Middle0.4727 EUR
BB Lower0.4582 EUR
BB Width6.11%
ATR (14)0.0128 EUR
Vol Ratio (20d)0.66x